Targeting IL-6 in the treatment of inflammatory and autoimmune diseases

C Ding, F Cicuttini, J Li, G Jones - Expert opinion on investigational …, 2009 - Taylor & Francis
Background: IL-6, a glycoprotein composed of 212 amino acids in human, has a wide range
of biological activity, including regulation of immune response, support of hematopoiesis …

Targeting interleukin-6 in rheumatoid arthritis

MY Md Yusof, P Emery - Drugs, 2013 - Springer
Abstract Interleukin (IL)-6 is a potent pro-inflammatory agent that plays a crucial role in the
pathogenesis of systemic inflammatory disease. Targeting this pathway in rheumatoid …

Immunotherapeutic implication of IL-6 blockade

T Tanaka, T Kishimoto - Immunotherapy, 2012 - Taylor & Francis
IL-6 is a cytokine featuring redundancy and pleiotropic activity. While IL-6 contributes to host
defense against acute environmental stress, continuous IL-6 production plays a significant …

Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions

A Ogata, T Tanaka - International journal of rheumatology, 2012 - Wiley Online Library
Interleukin (IL)‐6 is a cytokine featuring redundancy and pleiotropic activity. While IL‐6,
when transiently produced, contributes to host defense against acute environmental stress …

Inhibiting interleukin-6 in rheumatoid arthritis

E Choy - Current rheumatology reports, 2008 - Springer
Abstract Interleukin (IL)-6 is the most abundant proinflammatory cytokine in the circulation
and synovial joints of patients with active rheumatoid arthritis. It has pivotal roles in the …

Tocilizumab: an updated review of its use in the treatment of rheumatoid arthritis and its application for other immune-mediated diseases

T Tanaka, A Ogata, M Narazaki - Clinical Medicine Insights …, 2013 - journals.sagepub.com
Interleukin-6 (IL-6), produced by a variety of cells, is a typical cytokine featuring redundancy
and pleiotropic activity. IL-6 is promptly and transiently synthesized in response to infections …

The role and therapeutic targeting of IL-6 in rheumatoid arthritis

M Narazaki, T Tanaka, T Kishimoto - Expert review of clinical …, 2017 - Taylor & Francis
Introduction: Rheumatoid arthritis (RA) is an autoimmune chronic disease with joint and
systemic inflammation and it has been found that interleukin-6 (IL-6) plays a key role in RA …

Inhibition of IL-6 for the treatment of inflammatory diseases

N Nishimoto, T Kishimoto - Current opinion in pharmacology, 2004 - Elsevier
Interleukin-6 (IL-6) is a pleiotropic cytokine with various biological activities. Deregulated
overproduction of IL-6 has been found to play pathological roles in chronic inflammatory …

The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis

Y Ohsugi, T Kishimoto - Expert opinion on biological therapy, 2008 - Taylor & Francis
Background: IL-6 is a pro-inflammatory cytokine with multiple roles in the pathogenesis of
rheumatoid arthritis (RA). Targeting IL-6 with the humanized anti IL-6 receptor antibody …

Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders.

K Paul-Pletzer - Drugs of Today (Barcelona, Spain: 1998), 2006 - europepmc.org
Interleukin (IL)-6 contributes to a myriad of physiologic and pathophysiologic processes.
Among its many physiologic functions, IL-6 plays an active role in immunology, inflammatory …